Copyright
©The Author(s) 2018.
World J Gastroenterol. Nov 7, 2018; 24(41): 4691-4697
Published online Nov 7, 2018. doi: 10.3748/wjg.v24.i41.4691
Published online Nov 7, 2018. doi: 10.3748/wjg.v24.i41.4691
Table 3 In-hospital complications after endoscopic retrograde cholangiopancreatography from 2011 to 2013 based on data from the Nationwide Inpatient Sample comparing chronic kidney disease to controls n (%)
Type of complications | CKDn = 39403 | Controln = 445424 | CrudeOR/MD (95%CI) | AdjustedOR/MD (95%CI) | AdjustedP value |
Death | 1176 (3) | 5138 (1.15) | 2.6 (2.3-3.0) | 1.3 (1.14-1.55) | 0.001 |
Pancreatitis | 750 (6.8) | 20315 (4.6) | 1.5 (1.3-1.6) | 1.5 (1.3-1.7) | < 0.001 |
Bleeding | 1454 (3.7) | 6546 (1.5) | 2.56 (2.25–2.90) | 1.4 (1.2-1.6) | < 0.001 |
Perforation | 43 (0.1) | 340 (0.07) | 1.4 (0.7–2.9) | 1.36 (0.6–3.2) | 0.5 |
Length of hospital stay, mean days (SE) | 8.5 (0.11) | 6 (0.03) | 2.45 (2.24-2.67) | 1.4 (1.20-1.65) | < 0.001 |
- Citation: Sawas T, Bazerbachi F, Haffar S, Cho WK, Levy MJ, Martin JA, Petersen BT, Topazian MD, Chandrasekhara V, Abu Dayyeh BK. End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients. World J Gastroenterol 2018; 24(41): 4691-4697
- URL: https://www.wjgnet.com/1007-9327/full/v24/i41/4691.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i41.4691